Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 79.4051 USD -1.92%
Market Cap: 199.8B USD
Have any thoughts about
Merck & Co Inc?
Write Note

Intrinsic Value

The intrinsic value of one MRK stock under the Base Case scenario is 120.9159 USD. Compared to the current market price of 79.4051 USD, Merck & Co Inc is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRK Intrinsic Value
120.9159 USD
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Merck & Co Inc

Valuation History Unavailable

Historical valuation for MRK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
Compare MRK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heavily reliant on Keytruda’s continued success, Merck faces heightened risk if competitors launch effective immuno-oncology therapies or if pricing pressures intensify following patent expiration.

A weaker-than-expected pipeline, particularly in next-generation oncology and vaccines, raises concerns over Merck’s ability to sustain revenue growth after flagship products lose exclusivity.

Budgetary tightening and reimbursement restrictions in key markets could reduce patient access to Merck’s high-value therapies, pressuring margins and limiting overall sales growth.

Bull Theses

Keytruda’s dominant position in the immuno-oncology market and ongoing label expansions are poised to drive strong, sustained revenue and strengthen Merck’s leadership in cancer treatments.

Gardasil’s robust demand, reinforced by global vaccination campaigns, provides Merck with a reliable, high-margin revenue stream that can buoy earnings even if other franchises face headwinds.

A well-funded R&D engine, coupled with strategic in-licensing and acquisitions in areas like oncology, cardiovascular, and vaccines, positions Merck to deliver new blockbuster therapies long term.

Show More Less
How do you feel about MRK?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Merck & Co Inc

Provide an overview of the primary business activities
of Merck & Co Inc.

What unique competitive advantages
does Merck & Co Inc hold over its rivals?

What risks and challenges
does Merck & Co Inc face in the near future?

Has there been any significant insider trading activity
in Merck & Co Inc recently?

Summarize the latest earnings call
of Merck & Co Inc.

What significant events have occurred
in Merck & Co Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Merck & Co Inc.

Provide P/S
for Merck & Co Inc.

Provide P/E
for Merck & Co Inc.

Provide P/OCF
for Merck & Co Inc.

Provide P/FCFE
for Merck & Co Inc.

Provide P/B
for Merck & Co Inc.

Provide EV/S
for Merck & Co Inc.

Provide EV/GP
for Merck & Co Inc.

Provide EV/EBITDA
for Merck & Co Inc.

Provide EV/EBIT
for Merck & Co Inc.

Provide EV/OCF
for Merck & Co Inc.

Provide EV/FCFF
for Merck & Co Inc.

Provide EV/IC
for Merck & Co Inc.

Show me price targets
for Merck & Co Inc made by professional analysts.

What are the Revenue projections
for Merck & Co Inc?

How accurate were the past Revenue estimates
for Merck & Co Inc?

What are the Net Income projections
for Merck & Co Inc?

How accurate were the past Net Income estimates
for Merck & Co Inc?

What are the EPS projections
for Merck & Co Inc?

How accurate were the past EPS estimates
for Merck & Co Inc?

What are the EBIT projections
for Merck & Co Inc?

How accurate were the past EBIT estimates
for Merck & Co Inc?

Compare the revenue forecasts
for Merck & Co Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Merck & Co Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Merck & Co Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Merck & Co Inc compared to its peers.

Compare the P/E ratios
of Merck & Co Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Merck & Co Inc with its peers.

Analyze the financial leverage
of Merck & Co Inc compared to its main competitors.

Show all profitability ratios
for Merck & Co Inc.

Provide ROE
for Merck & Co Inc.

Provide ROA
for Merck & Co Inc.

Provide ROIC
for Merck & Co Inc.

Provide ROCE
for Merck & Co Inc.

Provide Gross Margin
for Merck & Co Inc.

Provide Operating Margin
for Merck & Co Inc.

Provide Net Margin
for Merck & Co Inc.

Provide FCF Margin
for Merck & Co Inc.

Show all solvency ratios
for Merck & Co Inc.

Provide D/E Ratio
for Merck & Co Inc.

Provide D/A Ratio
for Merck & Co Inc.

Provide Interest Coverage Ratio
for Merck & Co Inc.

Provide Altman Z-Score Ratio
for Merck & Co Inc.

Provide Quick Ratio
for Merck & Co Inc.

Provide Current Ratio
for Merck & Co Inc.

Provide Cash Ratio
for Merck & Co Inc.

What is the historical Revenue growth
over the last 5 years for Merck & Co Inc?

What is the historical Net Income growth
over the last 5 years for Merck & Co Inc?

What is the current Free Cash Flow
of Merck & Co Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Merck & Co Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Merck & Co Inc

Current Assets 35.5B
Cash & Short-Term Investments 9.2B
Receivables 11.6B
Other Current Assets 14.7B
Non-Current Assets 79.6B
Long-Term Investments 1.7B
PP&E 24.8B
Intangibles 37.4B
Other Non-Current Assets 15.6B
Current Liabilities 25.2B
Accounts Payable 3.8B
Accrued Liabilities 12.6B
Other Current Liabilities 8.8B
Non-Current Liabilities 41.6B
Long-Term Debt 33.5B
Other Non-Current Liabilities 8.1B
Efficiency

Free Cash Flow Analysis
Merck & Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Merck & Co Inc

Revenue
63.9B USD
Cost of Revenue
-14B USD
Gross Profit
50B USD
Operating Expenses
-28.3B USD
Operating Income
21.6B USD
Other Expenses
-4.2B USD
Net Income
17.4B USD
Fundamental Scores

MRK Profitability Score
Profitability Due Diligence

Merck & Co Inc's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Operating Income
68/100
Profitability
Score

Merck & Co Inc's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

MRK Solvency Score
Solvency Due Diligence

Merck & Co Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
65/100
Solvency
Score

Merck & Co Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 104.8334 USD with a low forecast of 82.82 USD and a high forecast of 153.3 USD.

Lowest
Price Target
82.82 USD
4% Upside
Average
Price Target
104.8334 USD
32% Upside
Highest
Price Target
153.3 USD
93% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MRK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MRK Insider Trading
Buy and sell transactions by insiders

MRK News

Other Videos
What is the Intrinsic Value of one MRK stock?

The intrinsic value of one MRK stock under the Base Case scenario is 120.9159 USD.

Is MRK stock undervalued or overvalued?

Compared to the current market price of 79.4051 USD, Merck & Co Inc is Undervalued by 34%.

Back to Top